A retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: Fluoroquinolones vs beta-lactams
International Journal of Antimicrobial Agents Jan 06, 2018
Mercuro NJ, et al. - Researchers planned this retrospective analysis comparing oral stepdown therapy [fluoroquinolone (FQ) vs beta-lactams (BLMs)] for Enterobacteriaceae bloodstream infections (EB-BSI). Observations revealed that oral BLMs were non-inferior to FQs as stepdown therapy for EB-BSI, with less antibiotic-associated adverse events.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
